NITROGLYCERIN TABLE

The Defense Logistics Agency awarded a delivery order, SPE2DP-26-F-7526, to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) on July 14, 2026, for the supply of one package of Nitroglycerin Tablets (NSN 6505011533379, NDC 00071-0418-13) under the basic contract SPE2DX-25-D-9900. The total contract value is $3.75, with no flexibility in quantity or pricing, indicating a firm-fixed-price transaction for a standardized pharmaceutical item. Delivery is required FOB destination to Fort Stewart, GA, no later than July 29, 2026, and the contractor must use traceable shipping methods—parcel post is expressly prohibited. All packaging and documentation must clearly display both the base contract number and the delivery order number in block letters, with no additional labeling, barcoding, or preservation requirements specified. The contract does not include formal FAR clauses or attachment lists, as these are incorporated by reference from the underlying indefinite delivery/indefinite quantity contract. The awardee is certified as a small business, a small disadvantaged business, and a women-owned small business, and the award was likely made under lowest price technically acceptable procedures given the low dollar value and commercial nature of the item. Inspection and acceptance occur at the destination by the government, and payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the appropriation code 97X4930 5CBX 001 2620 S33189. Contract administration is managed by Lisa Quinn, with support from DLA Troop Support’s Medical Supply Chain Pharm FSA in Philadelphia, though no formal COR or COTR is designated. The order aligns with standard DLA practices for low-value medical supplies, relying on the compliance framework of the NSN and NDC codes to ensure regulatory and quality standards are met without additional technical or performance specifications.